Second Affiliated Hospital Of Nanchang University
Clinical trials sponsored by Second Affiliated Hospital Of Nanchang University, explained in plain language.
-
New Triple-Threat attack on tough lung cancer aims to enable surgery
Disease control Recruiting nowThis study is testing a three-part treatment for stage III non-small cell lung cancer that cannot initially be removed by surgery. The goal is to see if combining a specialized form of radiation (SFRT) with an immunotherapy drug (tislelizumab) and standard chemotherapy can shrink…
Phase: PHASE2, PHASE3 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New Artery-Blocking procedure tested as alternative to pills for Tough-to-Treat high blood pressure
Disease control Recruiting nowThis study is testing if a minimally invasive procedure that blocks blood flow to the adrenal glands works as well as standard medication for people with primary aldosteronism, a hormone disorder that causes severe high blood pressure. Researchers will compare the artery-blocking…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Could a 'Poop Transplant' for your eyes cure dryness?
Disease control Recruiting nowThis early-stage study is testing whether transplanting healthy bacteria from a donor's eye to a patient's eye can help treat dry eye disease. It will involve 40 people with moderate to severe dry eye to see if this new approach reduces discomfort, improves tear production, and c…
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Gut bacteria vs. blurry future: probiotic tested to halt Kids' myopia
Disease control Recruiting nowThis study is testing whether a probiotic supplement called MR-61 can help slow down the progression of nearsightedness (myopia) in children and teenagers. About 164 participants aged 3 to 18 will be randomly assigned to receive either the probiotic or a placebo for a period of t…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for lung cancer patients when treatment fails and cancer spreads to brain
Disease control Recruiting nowThis study is testing a more intensive treatment for people with advanced lung cancer where the disease has spread to the lining of the brain and spinal cord (leptomeningeal metastasis) after their previous targeted therapy stopped working. Researchers want to see if giving a hig…
Phase: NA • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Drug vs diet: Head-to-Head test for new diabetes patients
Disease control Recruiting nowThis study is comparing two approaches for people newly diagnosed with type 2 diabetes who also have excess liver fat. For 12 weeks, one group will receive weekly injections of the medication semaglutide, while the other will follow a strict, reduced-calorie diet. Researchers wan…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
New injection combo aims to ease agony after shoulder repair
Disease control Recruiting nowThis study is testing if adding a long-acting numbing medicine to a standard anti-inflammatory steroid injection during shoulder surgery helps patients recover better. About 70 adults having surgery for a torn rotator cuff with shoulder stiffness will be randomly assigned to rece…
Phase: NA • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC